CTOs on the Move

Arriva Medical

www.arrivamedical.com

 
Arriva Medical is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Vbm Medical Inc

Vbm Medical Inc is a Noblesville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Katadyn North America

Katadyn North America is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Koya

Koya Medical is a transformative healthcare venture with a mission to treat cancer-related chronic lymphedema and venous diseases through innovative patient-centric platforms.

Lake Region Medical

Lake Region Medical collaborates with the world’s leading medical device companies to deliver life-changing innovations that enhance the lives of patients. Backed by decades of experience and clinical expertise, we help customers bring products from concept to point-of-care in the Cardio & Vascular and Advanced Surgical markets. Lake Region Medical offers fully-integrated outsourced manufacturing and engineering services, contract manufacturing, finished device assembly, original device development and supply chain management services.

Impedimed

ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.